Building predictions for atrial fibrillation in pacemaker patients
Part of Heart & circulation clinical trials.
This study creates a database to better predict who with a pacemaker or ICD will develop atrial fibrillation (an irregular heart rhythm). It may help your care team spot risk earlier and tailor monitoring sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a pacemaker or a defibrillator (ICD) with an atrial lead
- Your CHADS-VASc score is 2 or higher (a risk score based on health history)
- At your last device check, you were in normal heart rhythm or atrial-paced rhythm
- Your atrial stimulation (heart’s atrial pacing) is 50% or less
- Your device’s “mode switch” rate is 50% or less since the last device check
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for patterns that can predict an abnormal heart rhythm called SCAF in people who have a pacemaker or defibrillator. The goal is to help doctors recognize risk earlier and respond sooner if it happens.
This study looks at early changes in the heart related to atrial fibrillation (AF) using health data and biomarkers. It aims to find better ways to predict or understand AF, especially around procedures like ablation or cardioversion.
This study looks at how dual-chamber pacemakers affect atrial fibrillation (an irregular heartbeat). It aims to understand the benefits and risks of this type of pacemaker in managing this condition.
This trial tests a new type of pacemaker for people with atrial fibrillation who are scheduled for a procedure that disconnects the heart's natural electrical pathway. It may help improve symptoms and heart function.
This trial studies whether a strategy to regularize (control) heart rate can improve outcomes in people who have permanent atrial fibrillation and heart failure. It focuses on people with recent heart-failure hospitalization and checks several heart, kidney, and health-condition limits to keep the study safe.
This study tests a new catheter that uses pulsed field energy to treat atrial fibrillation (AF), a heart rhythm problem. It aims to see how well it reduces the amount of AF you have over time. If you have paroxysmal or persistent AF, this might be an option for you.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.